The word “theranostics” is a so-called “portmanteau” word made up from the words “therapeutics” and “diagnostics“. Thus, “theranostics” refers to the process of “diagnostic therapy” for individual patients. What exactly do we mean by this? … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: application, clinical, theranostics | 1 Comment »
According to an article in the journal Cancer, men with low-risk prostate cancer diagnosed and managed at high-volume hospitals are 3.6 times more likely to be managed on active surveillance than those managed at low-volume institutions. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, application, guidelines, variation | 2 Comments »
In addition to the new data from Johns Hopkins, reported earlier this week, that were highly supportive of active surveillance as a first-line management strategy for “favorable-risk” prostate cancer, another recent study has suggested that as many as 67 percent of newly diagnosed patients may be good candidates for such first-line management. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active, application, criteria, Management, surveillance | 10 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 